![](https://investorshub.advfn.com/uicon/171590.png?cb=1560959503)
Wednesday, September 15, 2010 4:26:02 PM
The response came from Inolife.
There is no requirement for us to provide an AABB number since we are not performing the actual laboratory testing. InoLife Technologies, Inc. is marketing this particular product directly to the Medical Market exclusively.
Regards,
Gary S. Berthold
CEO
InoLife Technologies, Inc.
8601 Six Forks Road
Suite 400
Raleigh, N. C. 27615
Tele: 919-676-5334
Fax: 919-900-8138
email: InoLife@nc.rr.com
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM